Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Potential psychotomimetics. Bromomethoxyamphetamines

C F Barfknecht, D E Nichols

    Journal of Medicinal Chemistry
    |April 1, 1971
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Psychedelics as Medicines: An Emerging New Paradigm.

    Clinical pharmacology and therapeutics·2016
    Same author

    D1 and functionally selective dopamine agonists as neuroprotective agents in Parkinson's disease.

    CNS & neurological disorders drug targets·2006
    Same author

    Distinct recognition of substrates by the human and Drosophila serotonin transporters.

    The Journal of pharmacology and experimental therapeutics·2003
    Same author

    Unilateral infusion of a dopamine transporter antisense into the substantia nigra protects against MDMA-induced serotonergic deficits in the ipsilateral striatum.

    Neuroscience·2002
    Same author

    Parkinson's disease and D1 dopamine receptors.

    Current opinion in investigational drugs (London, England : 2000)·2002
    Same author

    Robinlin: a novel bioactive homo-monoterpene from Robinia pseudoacacia L. (Fabaceae).

    Bioorganic & medicinal chemistry letters·2001
    Same journal

    A Melatonin-Catechol Hybrid Molecule Prolongs Lifespan via Regulating ROS and Reprogramming Mitochondrial Metabolism.

    Journal of medicinal chemistry·2026
    Same journal

    Discovery of SD-2301 as a Highly Potent and Selective PROTAC STAT3 Degrader Capable of Achieving Complete Tumor Regression with Single Administration.

    Journal of medicinal chemistry·2026
    Same journal

    GID4-Recruiting PROTACs for BRD4 Degradation Overcome Resistance Driven by CRBN and VHL Deficiency.

    Journal of medicinal chemistry·2026
    Same journal

    Alpha-Particle Therapy with an Actinium-225 Labeled Bivalent Inhibitor of Prostate-Specific Membrane Antigen is Therapeutically Efficacious in a Mouse Model of Prostate Cancer.

    Journal of medicinal chemistry·2026
    Same journal

    Development of Telmisartan Platinum(IV) Complexes for Antimetastatic Therapy: Targeting EMT and Tumor Immunity through Suppressing AT1R.

    Journal of medicinal chemistry·2026
    Same journal

    Library Docking for Cannabinoid-2 Receptor Ligands.

    Journal of medicinal chemistry·2026
    See all related articles